View Post

Women of All Ages with Breast Cancer Experience the Same Levels of Symptom Severity

In In The News by Barbara Jacoby

By: Colleen Moretti From: curetoday.com Both older and younger women with early breast cancer (EBC) being treated with the same chemotherapy experienced around the same levels of symptom severity and symptom-related adverse events, according to a study published in Cancer. It was unknown whether there was patient-reported symptom severity and symptom interference with daily activities difference in women under the …

View Post

Five Days of G-CSF Adequate for Breast Cancer Chemo

In In The News by Barbara Jacoby

fiBy: Charles Bankhead, Senior Editor From: medpagetoday.com Five days of prophylactic granulocyte colony-stimulating factor (G-CSF) proved as effective as 7 to 10 days for preventing chemotherapy-induced febrile neutropenia in patients with early breast cancer, a randomized trial showed. Patients assigned to the 5-day regimen of filgrastim (Neupogen) had a 2.09% incidence of febrile neutropenia or treatment-related hospitalization per cycle of …

View Post

Statins Might Reduce Harms From Breast Cancer Chemo

In Clinical Trials by Barbara Jacoby

By: Amy Norton From: usnews.com Cholesterol-lowering statins are commonly used to help prevent heart disease. Now a new study hints that they could shield women’s hearts from the harms of certain breast cancer drugs. The study focused on women in Canada who’d been treated with either chemotherapy drugs called anthracyclines or the medication Herceptin. Though the treatments can be lifesaving, …

View Post

Taking certain vitamins during breast cancer chemo tied to recurrence, death

In In The News by Barbara Jacoby

By: Linda Carroll From: reuters.com Patients with breast cancer who use supplements during chemotherapy may be at an increased risk of recurrence and death, a new study suggests. Use of dietary supplements that boost levels of antioxidants, iron, vitamin B12 and omega-3 fatty acids appeared to lower the effectiveness of chemotherapy, researchers report in the Journal of Clinical Oncology. “From …